Pharma Absent From 2013 M&A, But Expect Tides To Turn, Says EY / Big pharma was conspicuously absent from the M&A playing field in 2013, Ernst & Young points out in a report, but big biotech and specialty pharmas are making the deal landscape more competitive. / “The Pink Sheet” DAILY January 13 2014 12:05 AM
No comments:
Post a Comment